<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00918710</url>
  </required_header>
  <id_info>
    <org_study_id>AOM 08104</org_study_id>
    <nct_id>NCT00918710</nct_id>
  </id_info>
  <brief_title>Human Papillomavirus and Oropharynx Carcinoma</brief_title>
  <acronym>Papillophar</acronym>
  <official_title>Impact of the Human Papillomavirus (HPV) Status in Carcinologic Prognosis of Oropharynx Squamous Cell Carcinoma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High risk papillomavirus (HR-HPV) have an oncogenic role in Oropharyngeal squamous cell
      carcinomas (OP-SCC) in at least 25% of the cases and the prevalence is increasing. HPV+ might
      be more chemo and radio sensible with a better prognosis (disease-free survival (DFS) and
      overall survival (OS) as compared to HPV negative OP-SCC ; hypothesis : 2y DFS &gt; 20%
      improvement). The principal objective is to determine the impact of the status of HR-HPV in
      the prognosis of the OP-SCC. The principal criteria is the 2-years DFS.

      Secondary objective : virologic characteristics of HPV+ tumors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study has no impact on the treatment of the observed population. The clinical study
      include TNM status, previous story of HPV infection, smoking and alcoholic habits, treatment
      and outcome during 5 years. The virologic study include : HPV type, E6-E7 viral charge of
      HPV16, viral DNA integration in the tumoral genome, HPV16 variants, expression of HPV 16, 18,
      31, 45 coding oncoproteins E6-E7 mRNA. Moreover a serologic study will be done.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 2009</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>DFS at 2 years in HPV + and - tumors</measure>
    <time_frame>at 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>At 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HPV status</measure>
    <time_frame>At the inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>At 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">362</enrollment>
  <condition>Oropharyngeal Neoplasms</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients with oropharyngeal squamous cell carcinomas</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Pieces of Oropharyngeal squamous cell carcinomas biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with squamous cell carcinoma of oropharynx followed by the participating centers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Squamous cell carcinoma of Oropharynx proven histologically

          -  All stages TNM

          -  informed consent

          -  No previous or simultaneous Head Neck cancer

          -  Age &gt;18

        Exclusion Criteria:

          -  Squamous cell carcinoma other than oropharynx

          -  2nd synchronous SCC localization

          -  No consent

          -  age &lt; 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean LACAU, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tenon Hospital, APHP</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2009</study_first_submitted>
  <study_first_submitted_qc>June 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2009</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Squamous cell carcinoma of Oropharynx</keyword>
  <keyword>Human papillomavirus.</keyword>
  <keyword>Biological prognostic markers.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Oropharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

